Literature DB >> 20170293

Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964-2003 followed up to the end of 2006.

Timo Hakulinen1, Laufey Tryggvadóttir, Mette Gislum, Hans H Storm, Freddie Bray, Asa Klint, Gerda Engholm.   

Abstract

BACKGROUND: This is the first comprehensive population-based study on relative survival of lip, oral cavity and pharyngeal cancer in the Nordic countries.
MATERIAL AND METHODS: Relative survival of patients with cancers of the lip, oral cavity, and pharynx diagnosed in the Nordic countries in 1964-2003 and followed up to the end of 2006 was studied and contrasted with trends in incidence and mortality.
RESULTS: There are marked differences in incidence between countries and over time. The stability of the relative survival ratios gives support to the hypothesis that the incidence differences are more likely to be real and not materially affected by differences in definitions and coding. Of particular note are the steep rises in pharyngeal cancer incidence in Denmark in both sexes. Survival has only moderately improved over time and has tended to be slightly higher in females than males.
CONCLUSIONS: Co-morbidity caused by smoking and high alcohol consumption are likely to be partially responsible for differences between countries. Advances in therapy and standards of care are also likely to have played a role in the increasing survival trends.

Entities:  

Mesh:

Year:  2010        PMID: 20170293     DOI: 10.3109/02841860903575307

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany.

Authors:  Katrin Hertrampf; Jörg Wiltfang; Alexander Katalinic; Olaf Timm; Hans-Jürgen Wenz
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-14       Impact factor: 4.553

2.  Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.

Authors:  Lauri Jouhi; Neeta Datta; Suvi Renkonen; Timo Atula; Antti Mäkitie; Caj Haglund; Abdirisak Ahmed; Stina Syrjänen; Reidar Grénman; Eeva Auvinen; Sanna Lehtonen; Jaana Hagström
Journal:  Tumour Biol       Date:  2015-05-05

3.  A "package solution" fast track program can reduce the diagnostic waiting time in head and neck cancer.

Authors:  Jesper Roed Sorensen; Jørgen Johansen; Lars Gano; Jens Ahm Sørensen; Stine Rosenkilde Larsen; Peter Bøgeskov Andersen; Anders Thomassen; Christian Godballe
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-18       Impact factor: 2.503

4.  Factors related to late stage diagnosis of oral squamous cell carcinoma.

Authors:  Juan-Manuel Seoane-Romero; Inés Vázquez-Mahía; Juan Seoane; Pablo Varela-Centelles; Inmaculada Tomás; José-Luis López-Cedrún
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-01-01

5.  Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.

Authors:  Shunsuke Itai; Tomokazu Ohishi; Mika K Kaneko; Shinji Yamada; Shinji Abe; Takuro Nakamura; Miyuki Yanaka; Yao-Wen Chang; Shun-Ichi Ohba; Yasuhiko Nishioka; Manabu Kawada; Hiroyuki Harada; Yukinari Kato
Journal:  Oncotarget       Date:  2018-04-27

6.  Survival probabilities and trends for lip, oral cavity and oropharynx cancers in Northern Portugal in the period 2000-2009.

Authors:  Luís Silva Monteiro; Luís Antunes; Lúcio Lara Santos; Maria José Bento; Saman Warnakulasuriya
Journal:  Ecancermedicalscience       Date:  2018-07-31

7.  Oral Squamous Cell Carcinomas are Associated with Poorer Outcome with Increasing Ages.

Authors:  Tarinee Lubpairee; Catherine F Poh; Denise M Laronde; Miriam P Rosin; Lewei Zhang
Journal:  J Oncol Res Ther       Date:  2017-09-25

8.  Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer.

Authors:  Isabelle Soerjomataram; Joannie Lortet-Tieulent; Jacques Ferlay; David Forman; Colin Mathers; D Maxwell Parkin; Freddie Bray
Journal:  BMC Med Res Methodol       Date:  2012-08-17       Impact factor: 4.615

9.  Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2.

Authors:  Shunsuke Itai; Shinji Yamada; Mika K Kaneko; Masato Sano; Takuro Nakamura; Miyuki Yanaka; Saori Handa; Kayo Hisamatsu; Yoshimi Nakamura; Yoshikazu Furusawa; Masato Fukui; Tomokazu Ohishi; Manabu Kawada; Hiroyuki Harada; Yukinari Kato
Journal:  Biochem Biophys Rep       Date:  2018-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.